| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 51.07M | 50.13M | 47.30M | 44.79M | 28.20M |
| Gross Profit | 18.84M | 49.89M | 46.65M | 44.73M | 28.06M |
| EBITDA | 43.13M | 42.03M | 39.67M | 35.34M | 19.69M |
| Net Income | 26.32M | 26.11M | 24.59M | 21.98M | 11.23M |
Balance Sheet | |||||
| Total Assets | 420.83M | 431.54M | 433.29M | 454.25M | 460.88M |
| Cash, Cash Equivalents and Short-Term Investments | 23.94M | 20.21M | 25.84M | 45.19M | 127.10M |
| Total Debt | 7.72M | 7.72M | 2.19M | 2.99M | 3.76M |
| Total Liabilities | 26.14M | 27.56M | 21.34M | 23.31M | 21.55M |
| Stockholders Equity | 387.94M | 396.76M | 404.58M | 423.55M | 427.56M |
Cash Flow | |||||
| Free Cash Flow | 41.40M | 43.35M | 40.08M | -8.24M | 11.53M |
| Operating Cash Flow | 42.11M | 43.35M | 40.08M | 37.01M | 26.70M |
| Investing Cash Flow | -1.49M | -19.14M | -12.84M | -86.45M | -39.91M |
| Financing Cash Flow | -36.90M | -29.84M | -46.60M | -32.46M | 120.69M |
NewLake Capital Partners reported that for the fourth quarter of 2025, revenue was $12.3 million, with net income attributable to common stockholders of $6.0 million, funds from operations of $10.0 million and adjusted funds from operations of $10.6 million, while declaring a quarterly dividend of $0.43 per share. For the full year ended December 31, 2025, revenue rose modestly to $51.1 million and AFFO inched higher despite tenant vacancies tied to AYR Wellness and Revolutionary Clinics, as the company executed selective acquisitions in Ohio, completed a like-kind property exchange, and ended the year with $106.3 million of liquidity, minimal leverage and no debt maturities until May 2027.
During 2025 NewLake acquired two Ohio dispensaries with additional improvement commitments and swapped a Mokena, Illinois dispensary for a Brookville, Pennsylvania site, moves that modestly expanded and repositioned its portfolio in the face of industry tenant dislocation. Management highlighted that full-year performance exceeded 2024 levels despite these headwinds, pointing to disciplined portfolio management, re-tenanting efforts and strong balance sheet flexibility as key supports for sustaining its dividend and long-term value proposition to investors.
The most recent analyst rating on (NLCP) stock is a Buy with a $17.50 price target. To see the full list of analyst forecasts on NewLake Capital Partners stock, see the NLCP Stock Forecast page.